Journal profile

Seminars in liver disease

Publisher: Thieme
ISSN0272-8087 | 0272-0807 | 1098-8971 FormatPrint StatusCurrently indexed
Official Website Verify CrossRef

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.76
Citation rate 4.67 333 total citations
h5-index 28 h5 depth signal
Cited share 90.8% 69 of 76
Total citations 333 Citation footprint
Metric signal 6.06 External metric anchor
Self-citation 0.9% 3 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 215
Spain 48
China 37
United Kingdom 33
Italy 30

Citing Fields of Research

Liver Diseases 240
Hepatitis 168
Liver & Colon Cancer 56
Immunology 41
Transplantation 27

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 1,880 Articles tracked across the journal lifetime
Indexed publication set 76 69 cited publications
Last 12 months 19 2.1 publications/month
Open access share 21.1% 4 OA publications in the last year
Leading citing country United States 215 citing publications
Leading citing field Liver Diseases 240 citing publications
Latest tracked publication 19 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, 1981-
PubMed
v1n1, 1981-
Index medicus
Active Coverage

Research Focus & Classification

Indexed Subjects

Liver Diseases

Broad Categories

Gastroenterology Hepatitis Liver Diseases Substance Abuse Digestive Disorders Immunology Hematology

MeSH Descriptors

Liver Diseases

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Open DOI
Münevver Demir, Jakob Weglage, Michael Sigal
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by progressive fibroinflammatory injury of intrahepatic and extrahepatic bile ducts that may lead to cirrhosis, hepatobiliary malignancy, and death...
02
Open DOI
Matthew Carson, Vik Meadows, Kari Nejak-Bowen
Primary sclerosing cholangitis is a rare, progressive cholestatic liver disease of the intrahepatic and extrahepatic bile ducts with poor prognosis. The only life-extending treatment for PSC is liver transplantation, with up to 25% of po...
03
Open DOI
Paul Horn, Frank Tacke
Metabolic dysfunction-associated steatohepatitis is a consequence of pathological hepatocellular lipid accumulation where lipotoxic stress triggers chronic inflammation. Liver macrophages are important regulators in the transition from s...
04
Open DOI
Daniel Segna, Asunción Ojeda, Sonia Torres et al.
The purpose of these expert practical recommendations is to provide an updated, clinically oriented overview of the screening, diagnosis, treatment, and surveillance of portal hypertension (PH) in cirrhosis. Building on recent advances i...
07
Open DOI
Richa Gupta, Rodrigo M. Florentino, Amala Alenchery et al.
Bile secretion is dependent on the structural and functional integrity of membrane transport systems in hepatocytes and cholangiocytes. Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of disorders resulting ...
09
Open DOI
Kathryn Thompson, Hima Veeramachaneni, Ram Subramanian
Extracorporeal liver support (ECLS) systems provide detoxification and synthetic function support for patients with acute liver failure and acute-on-chronic liver failure to achieve spontaneous recovery of hepatic function or act as a br...
10
Open DOI
Ting Feng, Jiaming Li, Xiaoyi Ma et al.
Traditional classifications of metabolic dysfunction-associated steatotic liver disease (MASLD) based on histology or biochemical traits are insufficient to capture its complexity, and clinical strategies rely on generalized treatment ap...

Bibliographical & Catalog Notes

Title from cover.

Also issued online.

Vol. 14, no. 4 (NOV 1994)19950520 Notice not published Printed on acid-free paper